Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Themes | Quick Take |
|---|---|---|---|---|---|---|---|
Buyside Digest is not affiliated with, and does not endorse, Orbis International Equity. This analysis is provided for institutional research purposes only and is not investment advice.
"Orbis outperformed in volatile Q1 2026 through disciplined contrarian positioning. Semiconductor winners from AI boom offset healthcare losers from regulatory pressures and financial irregularities."
Orbis Global Equity generated a modest positive return in Q1 2026 while the MSCI World Index declined 3.6%, demonstrating the value of their contrarian approach emphasizing positive skew. Three semiconductor holdings were top contributors as AI boom beneficiaries, while seven healthcare positions were detractors. The manager sold problematic healthcare names including ICON (financial irregularities), UnitedHealth and Elevance (Medicare reimbursement pressures) while maintaining enthusiasm for biopharma and equipment makers. In semiconductors, they took profits on SK Square but maintain large positions in Taiwan Semiconductor, Samsung Electronics and SK Hynix, viewing favorable risk/reward despite cycle concerns. The Middle East conflict prompted strategic energy additions through EQT and Shell for portfolio protection. Software opportunities emerged from the SaaS sell-off, leading to a new Experian position focused on defensive network effects. The manager emphasizes adaptability without shortening investment horizons, continuously reorienting toward the most attractive opportunities while maintaining their disciplined, long-term philosophy that has delivered consistent outperformance across multiple time periods.
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Market Conviction
High-conviction positioning: Orbis outperformed in volatile Q1 2026 through disciplined contrarian positioning. Semiconductor winners from AI boom offset healthcare losers from regulatory pressures and financi...
Growth Outlook
Market outlook remains low conviction: Orbis outperformed in volatile Q1 2026 through disciplined contrarian positioning. Semiconductor winners from AI boom offset healthcare losers from regulatory pressures and financi...
Risk Appetite
Risk appetite posture is moderate conviction: Orbis outperformed in volatile Q1 2026 through disciplined contrarian positioning. Semiconductor winners from AI boom offset healthcare losers from regulatory pressures and financi...
Capital Deployment
Manager actively deployed capital into high-conviction opportunities. Orbis outperformed in volatile Q1 2026 through disciplined contrarian positioning. Semiconductor winners from AI boom offset healthcare losers from regulatory pressures and financi...
Forward Guidance
Forward guidance signal: Orbis outperformed in volatile Q1 2026 through disciplined contrarian positioning. Semiconductor winners from AI boom offset healthcare losers from regulatory pressures and financi...
Language Signal
Tone analysis indicates very low conviction language: Orbis outperformed in volatile Q1 2026 through disciplined contrarian positioning. Semiconductor winners from AI boom offset healthcare losers from regulatory pressures and financi...
Perceived Risk
Perceived risk level is evaluated as moderate conviction. Orbis outperformed in volatile Q1 2026 through disciplined contrarian positioning. Semiconductor winners from AI boom offset healthcare losers from regulatory pressures and financi...
Opportunity Density
Opportunity density index indicates moderate conviction actionable entry points. Orbis outperformed in volatile Q1 2026 through disciplined contrarian positioning. Semiconductor winners from AI boom offset healthcare losers from regulatory pressures and financi...
Time Horizon
Investment time horizon reflects a moderate conviction orientation. Orbis outperformed in volatile Q1 2026 through disciplined contrarian positioning. Semiconductor winners from AI boom offset healthcare losers from regulatory pressures and financi...
